Dry Powder: The Private Equity Podcast
On the previous episode of Dry Powder, I asked two of the leading investors at Welsh, Carson, Anderson & Stowe (WCAS) how they go about succession planning. Today on the show, we turn our attention to the firm’s unique approach to sector expertise. WCAS may be one of the only private equity firms out there that evenly splits its deals between healthcare and tech.
“It’s just a really naturally complementary and mutually beneficial strategy to pursue both these industries with separate but highly collaborative teams,” Mike Donovan, head of WCAS’s Technology Group, tells me.
I’ll ask how they seamlessly share insights and resources across the deal life cycle. Moreover, we’ll examine the unique investment opportunities that arise at the intersection of healthcare and tech.
“We think of it as somewhat of a sweet spot between diversification and focus,” says Brian Regan, head of the Healthcare Group.